EdgarLookup

X4 Pharmaceuticals, Inc — All Filings

786 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B1 424B3 424B5 425 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP PRE 14A S-1 S-1/A S-3 S-3/A S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
4 FORM 4 SUBMISSION 0000899243-17-027830 Dec 1, 2017 Nov 15, 2017
4 FORM 4 SUBMISSION 0000899243-17-027832 Dec 1, 2017 Nov 15, 2017
4 FORM 4 SUBMISSION 0000899243-17-027823 Dec 1, 2017 Nov 15, 2017
4 FORM 4 SUBMISSION 0000899243-17-027822 Dec 1, 2017 Nov 15, 2017
4 FORM 4 SUBMISSION 0000899243-17-027824 Dec 1, 2017 Nov 15, 2017
SC 13D SCHEDULE 13D 0000947871-17-000977 Nov 30, 2017
SC 13D SC 13D 0001193125-17-355669 Nov 29, 2017
SC 13D NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D 0001072613-17-000603 Nov 29, 2017
8-K 8-K 0001193125-17-348213 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061778 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027017 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061776 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061775 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061773 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061772 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061770 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061767 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061766 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061764 Nov 20, 2017
3 FORM 3 SUBMISSION 0001209191-17-061763 Nov 20, 2017
4 FORM 4 0001722024-17-000004 Nov 20, 2017 Nov 15, 2017
3 FORM 3 SUBMISSION 0001209191-17-061765 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027103 Nov 20, 2017
4 0000898432-17-001103 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027028 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027016 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027015 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027011 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027009 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027007 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027004 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027003 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-027002 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-026998 Nov 20, 2017
4 FORM 4 SUBMISSION 0000899243-17-026997 Nov 20, 2017
424B1 424B1 0001193125-17-345863 Nov 17, 2017
CT ORDER 9999999997-17-009909 Nov 16, 2017
S-8 S-8 0001193125-17-345721 Nov 16, 2017
3 FORM 3 SUBMISSION 0000899243-17-026380 Nov 15, 2017
EFFECT 9999999995-17-002979 Nov 15, 2017
3 FORM 3 0001722024-17-000002 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026409 Nov 15, 2017
3 0000898432-17-001046 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026404 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026402 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026401 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026400 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026399 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026396 Nov 15, 2017
3 FORM 3 SUBMISSION 0000899243-17-026395 Nov 15, 2017